Summary

The Asia-Pacific flow cytometry market is expected to reach USD 3.25 billion by 2032 from USD 1.29 billion in 2024, growing at a CAGR of 12.2% in the forecast period of 2025 to 2032.

Market Segmentation:
Asia-Pacific Flow Cytometry Market, By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End user (Pharmaceuticals and Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, CRO, Blood Bank, CMO & CDMO, Forensic Laboratories, and Others), Distribution Channel (Retail Sales and Direct Tenders), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Vietnam, Philippines, and Rest of Asia-Pacific) - Industry Trends & Forecast To 2032

Overview of Asia-Pacific Flow Cytometry Market Dynamics:

Driver
• Rising Prevalence of Chronic Diseases
Restrain

• High Cost of Flow Cytometry Instruments

Opportunity

• Increase in Adoption of Flow Cytometry Techniques in Research and Academia

Market Players:

The key market players operating in the Asia-Pacific flow cytometry market are listed below:

• BD
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Bennubio Inc.
• Enzo Biochem Inc.
• Apogee Flow Systems Ltd.
• Beckman Coulter, Inc.
• Coherent Corp.
• Cell Signaling Technology, Inc.
• Cytek Biosciences
• Biomérieux
• Cytonome/ST LLC

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 75
1.1 OBJECTIVES OF THE STUDY 75
1.2 MARKET DEFINITION 75
1.3 OVERVIEW OF THE ASIA-PACIFIC FLOW CYTOMETRY MARKET 75
1.4 CURRENCY AND PRICING 77
1.5 LIMITATIONS 77
1.6 MARKETS COVERED 77
2 MARKET SEGMENTATION 80
2.1 MARKETS COVERED 80
2.2 GEOGRAPHICAL SCOPE 81
2.3 YEARS CONSIDERED FOR THE STUDY 82
2.4 DBMR TRIPOD DATA VALIDATION MODEL 83
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 86
2.6 MULTIVARIATE MODELLING 87
2.7 DBMR MARKET POSITION GRID 88
2.8 VENDOR SHARE ANALYSIS 89
2.9 SECONDARY SOURCES 90
2.10 ASSUMPTIONS 90
3 EXECUTIVE SUMMARY 91
4 PREMIUM INSIGHTS 96
4.1 PESTAL ANALYSIS 97
4.2 PORTERS FIVE FORCES ANALYSIS 98
5 ASIA-PACIFIC FLOW CYTOMETRY MARKET: REGULATIONS 99
6 MARKET OVERVIEW 101
6.1 DRIVERS 103
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 103
6.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 104
6.1.3 GROWING USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 105
6.1.4 GROWING RESEARCH FUNDING 106
6.2 RESTRAINTS 107
6.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 107
6.2.2 LIMITATIONS OF FLOW CYTOMETRY 107
6.3 OPPORTUNITIES 109
6.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 109
6.3.2 RISING DEVELOPMENT OF PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 109
6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 110
6.4 CHALLENGES 111
6.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 111
6.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 111
7 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY PRODUCT 113
7.1 OVERVIEW 114
7.2 REAGENTS AND CONSUMABLES 117
7.2.1 DYE 118
7.2.2 ANTIBODIES 118
7.2.3 BEADS 118
7.2.4 OTHERS 118
7.3 FLOW CYTOMETRY INSTRUMENTS 118
7.3.1 CELL ANALYZERS 120
7.3.1.1 CELL ANALYZERS, BY TYPE 120
7.3.1.1.1 IMAGING FLOW CYTOMETERS 120
7.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 120
7.3.1.2 CELL ANALYZERS, BY RANGE 121
7.3.1.2.1 HIGH-RANGE CELL ANALYZERS 121
7.3.1.2.2 MID-RANGE CELL ANALYZERS 121
7.3.1.2.3 LOW-RANGE CELL ANALYZERS 121
7.3.1.3 CELL ANALYZERS, BY MODALITY 121
7.3.1.3.1 BENCHTOP 122
7.3.1.3.2 STANDALONE 122
7.3.2 CELL SORTERS 122
7.3.2.1 BENCHTOP 122
7.3.2.2 STANDALONE 122
7.3.3 CELL SORTERS 122
7.3.3.1 HIGH-RANGE CELL ANALYZERS 123
7.3.3.2 MID-RANGE CELL ANALYZERS 123
7.3.3.3 LOW-RANGE CELL ANALYZERS 123
7.4 ACCESSORIES 124
7.4.1 FILTERS 125
7.4.2 DETECTORS 125
7.4.3 OTHERS 125
7.5 SERVICES 126
7.6 SOFTWARE 126
8 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY 127
8.1 OVERVIEW 128
8.2 CELL-BASED FLOW CYTOMETRY 131
8.2.1 FLOW CYTOMETRY INSTRUMENTS 132
8.2.2 REAGENTS & CONSUMABLES 132
8.2.3 ACCESSORIES 132
8.3 BEAD-BASED FLOW CYTOMETRY 132
8.3.1 FLOW CYTOMETRY INSTRUMENTS 132
8.3.2 REAGENTS & CONSUMABLES 132
8.3.3 ACCESSORIES 132
9 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION 133
9.1 OVERVIEW 134
9.2 RESEARCH APPLICATIONS 137
9.2.1 CELL CYCLE ANALYSIS 138
9.2.2 CELL SORTING/SCREENING 138
9.2.3 CELL TRANSFECTION/VIABILITY 138
9.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 138
9.2.4.1 DRUG DISCOVERY 138
9.2.4.2 STEM CELL RESEARCH 138
9.2.4.3 IN VITRO TOXICITY TESTING 138
9.2.5 IMMUNOLOGY 139
9.2.6 APOPTOSIS 139
9.2.7 CELL COUNTING 139
9.2.8 OTHERS 139
9.3 CLINICAL APPLICATIONS 139
9.3.1 HAEMATOLOGY 140
9.3.2 CANCER 140
9.3.3 IMMUNODEFICIENCY DISEASES 140
9.3.4 ORGAN TRANSPLANTATION 140
9.3.5 OTHER CLINICAL APPLICATION 140
9.4 INDUSTRIAL APPLICATIONS 140
10 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 141
10.1 OVERVIEW 142
10.2 RETAIL SALES 145
10.2.1 OFFLINE 145
10.2.2 ONLINE 145
10.3 DIRECT TENDERS 146
11 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY END USER 147
11.1 OVERVIEW 148
11.2 PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES 151
11.3 ACADEMIC & RESEARCH INSTITUTES 152
11.4 HOSPITALS 152
11.5 CLINICAL TESTING LABORATORIES 153
11.6 CRO 153
11.7 BLOOD BANK 154
11.8 CMO & CDMO 154
11.9 FORENSIC LABORATORIES 155
11.10 OTHERS 155
12 ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY REGION 156
12.1 ASIA-PACIFIC 158
12.1.1 JAPAN 168
12.1.2 CHINA 177
12.1.3 INDIA 185
12.1.4 SOUTH KOREA 193
12.1.5 AUSTRALIA 202
12.1.6 SINGAPORE 210
12.1.7 THAILAND 218
12.1.8 MALAYSIA 226
12.1.9 INDONESIA 234
12.1.10 PHILIPPINES 242
12.1.11 REST OF ASIA-PACIFIC 251
13 ASIA-PACIFIC FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 252
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS 253
15 COMPANY PROFILES 254
15.1 BD 254
15.1.1 COMPANY SNAPSHOT 254
15.1.2 REVENUE ANALYSIS 254
15.1.3 COMPANY SHARE ANALYSIS 255
15.1.4 PRODUCT PORTFOLIO 255
15.1.5 RECENT DEVELOPMENT 258
15.2 AGILENT TECHNOLOGIES, INC. 259
15.2.1 COMPANY SNAPSHOT 259
15.2.2 REVENUE ANALYSIS 259
15.2.3 COMPANY SHARE ANALYSIS 260
15.2.4 PRODUCT PORTFOLIO 260
15.2.5 RECENT DEVELOPMENT 262
15.3 THERMO FISHER SCIENTIFIC INC 263
15.3.1 COMPANY SNAPSHOT 263
15.3.2 REVENUE ANALYSIS 264
15.3.3 COMPANY SHARE ANALYSIS 264
15.3.4 PRODUCT PORTFOLIO 264
15.3.5 RECENT DEVELOPMENT 267
15.4 BIO-RAD LABORATORIES, INC. 268
15.4.1 COMPANY SNAPSHOT 268
15.4.2 REVENUE ANALYSIS 268
15.4.3 COMPANY SHARE ANALYSIS 269
15.4.4 PRODUCT PORTFOLIO 269
15.4.5 RECENT DEVELOPMENT 270
15.5 SARTORIUS AG 271
15.5.1 COMPANY SNAPSHOT 271
15.5.2 REVENUE ANALYSIS 272
15.5.3 COMPANY SHARE ANALYSIS 272
15.5.4 PRODUCT PORTFOLIO 272
15.5.5 RECENT DEVELOPMENT 274
15.6 APOGEE FLOW SYSTEMS LTD. 275
15.6.1 COMPANY SNAPSHOT 275
15.6.2 PRODUCT PORTFOLIO 275
15.6.3 RECENT DEVELOPMENT 275
15.7 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 276
15.7.1 COMPANY SNAPSHOT 276
15.7.2 REVENUE ANALYSIS 276
15.7.3 PRODUCT PORTFOLIO 277
15.7.4 RECENT DEVELOPMENT 278
15.8 BIOMÉRIEUX 280
15.8.1 COMPANY SNAPSHOT 280
15.8.2 REVENUE ANALYSIS 280
15.8.3 PRODUCT PORTFOLIO 281
15.8.4 RECENT DEVELOPMENT 281
15.9 BIOLEGEND, INC. 282
15.9.1 COMPANY SNAPSHOT 282
15.9.2 PRODUCT PORTFOLIO 282
15.9.3 RECENT DEVELOPMENT 282
15.10 BENNUBIO INC 283
15.10.1 COMPANY SNAPSHOT 283
15.10.2 PRODUCT PORTFOLIO 283
15.10.3 RECENT DEVELOPMENT 283
15.11 COHERENT CORP. 284
15.11.1 COMPANY SNAPSHOT 284
15.11.2 REVENUE ANALYSIS 284
15.11.3 PRODUCT PORTFOLIO 285
15.11.4 RECENT DEVELOPMENT 285
15.12 CYTONOME/ST, LLC 286
15.12.1 COMPANY SNAPSHOT 286
15.12.2 PRODUCT PORTFOLIO 286
15.12.3 RECENT DEVELOPMENTS 287
15.13 CYTOBUOY 288
15.13.1 COMPANY SNAPSHOT 288
15.13.2 PRODUCT PORTFOLIO 288
15.13.3 RECENT DEVELOPMENT 289
15.14 CELL SIGNALING TECHNOLOGY, INC 290
15.14.1 COMPANY SNAPSHOT 290
15.14.2 PRODUCT PORTFOLIO 290
15.14.3 RECENT DEVELOPMENT 291
15.15 CYTEK BIOSCIENCES 292
15.15.1 COMPANY SNAPSHOT 292
15.15.2 PRODUCT PORTFOLIO 292
15.15.3 RECENT DEVELOPMENT 293
15.16 DIASORIN S.P.A. 294
15.16.1 COMPANY SNAPSHOT 294
15.16.2 REVENUE ANALYSIS 294
15.16.3 PRODUCT PORTFOLIO 295
15.16.4 RECENT DEVELOPMENT 295
15.17 ELABSCIENCE BIONOVATION INC. 296
15.17.1 COMPANY SNAPSHOT 296
15.17.2 PRODUCT PORTFOLIO 296
15.17.3 RECENT DEVELOPMENT 297
15.18 ENZO BIOCHEM, INC 298
15.18.1 COMPANY SNAPSHOT 298
15.18.2 REVENUE ANALYSIS 298
15.18.3 PRODUCT PORTFOLIO 299
15.18.4 RECENT DEVELOPMENT 300
15.19 MILTENYI BIOTEC AND/OR ITS AFFILIATES 301
15.19.1 COMPANY SNAPSHOT 301
15.19.2 PRODUCT PORTFOLIO 301
15.19.3 RECENT DEVELOPMENT 303
15.20 MERCK KGAA 304
15.20.1 COMPANY SNAPSHOT 304
15.20.2 REVENUE ANALYSIS 304
15.20.3 PRODUCT PORTFOLIO 305
15.20.4 RECENT DEVELOPMENT 306
15.21 NANOCELLECT BIOMEDICAL 307
15.21.1 COMPANY SNAPSHOT 307
15.21.2 PRODUCT PORTFOLIO 307
15.21.3 RECENT DEVELOPMENTS 308
15.22 NEOGENOMICS LABORATORIES 310
15.22.1 COMPANY SNAPSHOT 310
15.22.2 REVENUE ANALYSIS 311
15.22.3 PRODUCT PORTFOLIO 311
15.22.4 RECENT DEVELOPMENT 311
15.23 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 312
15.23.1 COMPANY SNAPSHOT 312
15.23.2 PRODUCT PORTFOLIO 312
15.23.3 RECENT DEVELOPMENTS 313
15.24 ORLFO TECHNOLOGIES 314
15.24.1 COMPANY SNAPSHOT 314
15.24.2 PRODUCT PORTFOLIO 314
15.24.3 RECENT DEVELOPMENT 314
15.25 STRATEDIGM, INC 315
15.25.1 COMPANY SNAPSHOT 315
15.25.2 PRODUCT PORTFOLIO 315
15.25.3 RECENT DEVELOPMENTS 316
15.26 SONY BIOTECHNOLOGY INC 317
15.26.1 COMPANY SNAPSHOT 317
15.26.2 PRODUCT PORTFOLIO 317
15.26.3 RECENT DEVELOPMENT 319
15.27 SYSMEX ASIA PACIFIC PTE LTD (PART OF SYSMEX CORPORATION) 320
15.27.1 COMPANY SNAPSHOT 320
15.27.2 REVENUE ANALYSIS 320
15.27.3 PRODUCT PORTFOLIO 321
15.27.4 RECENT DEVELOPMENT 322
15.28 TAKARA BIO INC. 323
15.28.1 COMPANY SNAPSHOT 323
15.28.2 PRODUCT PORTFOLIO 323
15.28.3 RECENT DEVELOPMENT 324
15.29 UNION BIOMETRICA, INC. 325
15.29.1 COMPANY SNAPSHOT 325
15.29.2 PRODUCT PORTFOLIO 325
15.29.3 RECENT DEVELOPMENTS 326
16 QUESTIONNAIRE 328
17 RELATED REPORTS 331